1338812-45-5Relevant articles and documents
Discovery of aryloxy tetramethylcyclobutanes as novel androgen receptor antagonists
Guo, Chuangxing,Linton, Angelica,Kephart, Susan,Ornelas, Martha,Pairish, Mason,Gonzalez, Javier,Greasley, Samantha,Nagata, Asako,Burke, Benjamin J.,Edwards, Martin,Hosea, Natilie,Kang, Ping,Hu, Wenyue,Engebretsen, Jon,Briere, David,Shi, Manli,Gukasyan, Hovik,Richardson, Paul,Dack, Kevin,Underwood, Toby,Johnson, Patrick,Morell, Andrew,Felstead, Robert,Kuruma, Hidetoshi,Matsimoto, Hiroaki,Zoubeidi, Amina,Gleave, Martin,Los, Gerrit,Fanjul, Andrea N.
, p. 7693 - 7704 (2011)
An aryloxy tetramethylcyclobutane was identified as a novel template for androgen receptor (AR) antagonists via cell-based high-throughput screening. Follow-up to the initial "hit" established 5 as a viable lead. Further optimization to achieve full AR antagonism led to the discovery of 26 and 30, both of which demonstrated excellent in vivo tumor growth inhibition upon oral administration in a castration-resistant prostate cancer (CRPC) animal model.
